Editorial Board
Editor-in-Chief
- Alexander M. M. Eggermont, MD, PhD, University Medical Centre Utrecht, Utrecht, Netherlands
Editorial Office
- EJC Editorial Office, Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, , UKemail: [email protected]
Editor: Basic Science and Preclinical Research
- Ulrich Keilholz, Dr. med., Charite University Hospital Berlin Centre 10 Charite Comprehensive Cancer Center, Berlin, Germany
Editor: Epidemiology and Prevention
- Valery E. Lemmens, Comprehensive Cancer Centre South, Eindhoven, Netherlands
Editor: Tumour Immunotherapy
- Aurelien Marabelle, MD, PhD, Gustave Roussy, Villejuif, France
Editors: Breast Cancer
- Giuseppe Curigliano, MD, PhD, European Institute of Oncology, Milano, Italy
- Suzette Delaloge, MD, MSc, Gustave Roussy, Villejuif, France
Editors: Gastrointestinal Cancers
- Michel Ducreux, Gustave Roussy, Villejuif, France
- Volker Heinemann, Ludwig Maximilians University Munich, München, Germany
Editor: Genitourinary Cancers
- Karim Fizazi, MD, PhD, Gustave Roussy, Department of Oncological Medicine, Villejuif, France
Editor: Head and Neck Cancer
- Jean-Pascal Machiels, University Hospital Saint-Luc, Bruxelles, Belgium
Editor: Hemato-Oncology
- Roch Houot, Rennes 1 University, Rennes, France
Editor: Lung Cancer
- Joachim G. Aerts, MD, PhD, Erasmus Medical Center, Rotterdam, Netherlands
- Martin Schuler, Univ-Prof. Dr. med., University of Duisburg-Essen, Duisburg, Germany
Editor: Gynaecological Cancers
- Ignace Vergote, KU Leuven University Hospitals Leuven, Leuven, Belgium
Editor: Endocrine, Sarcomas and Other Rare Tumours
- Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands
Editor: Melanoma
- Jessica Hassel, Prof. Dr. med, University Hospital Heidelberg, Heidelberg, Germany
Editor: Neuro-oncology
- Martin van den Bent, Erasmus MC Cancer Centre, Rotterdam, Netherlands
Editor: Paediatric Oncology
- Birgit Geoerger, MD, PhD, Gustave Roussy, Villejuif, France
Section Editor
- Titus Brinker, MD, Dr. med., German Cancer Research Center, Heidelberg, Germany
Clinical Oncology Editorial Board
- A.C.J. van Akkooi, M.D, PhD, Melanoma Institute Australia, North Sydney, Australia
- Richard Baird, University of Cambridge, Cambridge, United Kingdom
- Raffaele Califano, MD, The Christie NHS Foundation Trust, Manchester, United Kingdom
- Emiliano Calvo, START International Inc., Madrid-CIOCC, Ctro Integral Oncológico Clara Campal, Hospital Universitario Madrid Norte Sanchinarro, Madrid, Spain
- Fatima Cardoso, MD, Champalimaud Clinical Centre, Lisboa, Portugal
- Elisabeth G De Vries, Academic Medical Centre Groningen, Groningen, Netherlands
- Adam Dicker, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Reinhard Dummer, University of Zurich, Zurich, Switzerland
- Sara Erridge, The University of Edinburgh, Edinburgh, United Kingdom
- Birgit Geoerger, MD, PhD, INSERM U749, Villejuif, France
- John Haanen, MD, PhD, Amsterdam, Amsterdam, Netherlands
- Baktiar Hasan, European Organisation for Research and Treatment of Cancer, Brussels, Belgium
- Jean-Claude Horiot, Institut Multidisciplinaire d'Oncologie, Genolier clinic, Genolier, Switzerland
- Dirk Jäger, German Cancer Research Center, Heidelberg, Germany
- Artur Katz, Syrian-Lebanese Hospital, SAO PAULO, Brazil
- Paul Lorigan, Christie Hospital, Manchester, United Kingdom
- Yohann Loriot, MD, PhD, INSERM U749, Villejuif, France
- Christophe Massard, MD, PhD, INSERM U749, Villejuif, France
- Kerrie McDonald, University of New South Wales, Sydney, New South Wales, Australia
- Françoise Meunier, Federation of European Academies of Medicine (FEAM), Brussels, Belgium
- Tony Mok, The Chinese University of Hong Kong, Dept. of Clinical Oncology, Hong Kong, Hong Kong
- Do-Hyun Nam, Sungkyunkwan University, Jongno-gu, South Korea
- James Perry, Sunnybrook Research Institute, Toronto, Ontario, Canada
- Achim Rody, University of Lübeck, Lübeck, Germany
- Manuela Schmidinger, Medical University of Vienna, Wien, Austria
- Jean-Charles Soria, INSERM U749, Villejuif, France
- Silvia Stacchiotti, Fondazione IRCCS Istituto Nazionale Tumori, Cancer Medicine Department, Adult mesenchymal tumour & Rare cancer Medical Oncology Unit, Milano, Italy
- Cora Sternberg, MD, FACP, Vincenzo Pansadoro Foundation, Roma, Italy
- Eric Van Cutsem, MD, PhD, KU Leuven, Department of Oncology, Leuven, Belgium
- Galina Velikova, University of Leeds, Leeds, United Kingdom
- Eric Winquist, London Health Sciences Centre, London, Ontario, Canada
- Timothy Yap, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
Basic Science and Preclinical Research Editorial Board
- Paola Allavena, Humanitas Research Hospital Cellular Immunology Lab, Rozzano, Milan, Italy
- John Anderson, BA MBBS MRCP PhD, University College London Institute of Child Health, London, United Kingdom
- Massimo Broggini, Mario Negri Institute for Pharmacological Research, Milano, Italy
- Christophe Caux, Centre Léon Bérard, Dept. of Medical Oncology, Lyon, France
- Manel Esteller, M.D., Ph.D., Research Institute Against Leukemia Josep Carreras, Barcelona, Spain
- Enrico Garattini, Mario Negri Institute for Pharmacological Research, Milano, Italy
- J.M. Irish, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
- John Lunec, Newcastle University, Newcastle Upon Tyne, United Kingdom
- Antonia Maria Müller, University of Zurich, Zurich, Switzerland
- Daniel Olive, Aix-Marseille I University, Marseille, France
- Athanasios Papavassiliou, National and Kapodistrian University of Athens School of Health Sciences, Athens, Greece
- Giorgio Parmiani, San Raffaele Hospital, Milano, Italy
- Victoria Sanz-Moreno, King's College London, London, United Kingdom
- Sheila Singh, McMaster University, Hamilton, Ontario, Canada
- John Stagg, University of Montreal, Montréal, Quebec, Canada
- Amaya Virós, Cancer Research UK, Macclesfield, United Kingdom
- Britta Weigelt, MEMORIAL SLOAN KETTERING CANCER CENTER, New York, New York, United States of America
- Nadia Zaffaroni, Fondazione IRCCS Istituto Nazionale Tumori, Department of Applied Research and Technological Development, Milano, Italy
Epidemiology and Prevention Editorial Board
- Philippe Autier, International Prevention Research Institute, Lyon, France
- Marianne Berwick, , New Mexico, United States of America
- Nirmala Bhoo Pathy, Kuala Lumpur, Malaysia
- Paolo Boffetta, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
- Cristina Bosetti, Mario Negri Institute for Pharmacological Research, Milano, Italy
- Emanuele Crocetti, Florence, Italy
- Christine Friedenreich, MSc, PhD, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
- Gemma Gatta, Milan, Milano, Italy
- Iris Lansdorp-Vogelaar, Erasmus University Rotterdam, Rotterdam, Netherlands
- Marc Maynadié, University Hospital Centre Dijon Bourgogne, Dijon, France
- Henrik Møller, King's College London, London, United Kingdom
- Eleni Petridou, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece
- Lonneke van de Poll-Franse, Catharina Hospital, Eindhoven, Netherlands
- Marjanka Schmidt, Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Netherlands
- Isabelle Soerjomataram, International Agency for Research on Cancer, Lyon, France
- Esther de Vries, Erasmus University Rotterdam, Rotterdam, Netherlands
Paediatric Oncology Editorial Board
- Christophe Bergeron, Institute of Paediatric Haematology and Oncology, Lyon, France
- Eric Bouffet, The Hospital for Sick Children, Toronto, Ontario, Canada
- Mitchell Cairo, MD, New York Medical College, Valhalla, New York, United States of America
- Guillermo Chantada, Hospital JP Garrahan, Buenos Aires, Argentina
- Francois Doz, Institute Curie, Paris, France
- Andrea Ferrari, Foundation IRCCS National Cancer Institute, Milano, Italy
- Martha A. Grootenhuis, Amsterdam UMC Location AMC, Amsterdam, Netherlands
- Marry van den Heuvel-Eibrink, Erasmus University Rotterdam, Rotterdam, Netherlands
- Max van Noesel, Erasmus MC Sophia Children Hospital, Rotterdam, Netherlands
- Kathy Pritchard-Jones, University College London, London, United Kingdom
- Lillian Sung, The Hospital for Sick Children, Toronto, Ontario, Ontario, Canada
